KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 141 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $82,000 | -41.4% | 11,335 | -52.5% | 0.00% | -33.3% |
Q4 2016 | $140,000 | -32.4% | 23,870 | -38.7% | 0.00% | -40.0% |
Q3 2016 | $207,000 | -48.1% | 38,949 | -54.4% | 0.01% | -54.5% |
Q1 2016 | $399,000 | +50.0% | 85,452 | +62.4% | 0.01% | +120.0% |
Q4 2015 | $266,000 | +491.1% | 52,634 | +312.8% | 0.01% | +400.0% |
Q3 2015 | $45,000 | -78.9% | 12,751 | -40.2% | 0.00% | -75.0% |
Q2 2015 | $213,000 | -28.5% | 21,321 | -9.0% | 0.00% | -33.3% |
Q1 2015 | $298,000 | +19.2% | 23,436 | +32.8% | 0.01% | +50.0% |
Q4 2014 | $250,000 | -7.4% | 17,645 | +0.4% | 0.00% | 0.0% |
Q2 2014 | $270,000 | -28.0% | 17,580 | -52.6% | 0.00% | -20.0% |
Q3 2013 | $375,000 | – | 37,126 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 1,605,800 | $16,026,000 | 4.65% |
Baupost Group | 25,791,678 | $257,401,000 | 4.29% |
1492 Capital Management LLC | 264,297 | $2,638,000 | 1.67% |
Cormorant Asset Management, LP | 826,000 | $8,243,000 | 1.10% |
FALCON POINT CAPITAL, LLC | 251,137 | $2,506,000 | 0.85% |
OAK RIDGE INVESTMENTS LLC | 3,291,711 | $32,851,000 | 0.70% |
Knoll Capital Management, LLC | 200,000 | $1,996,000 | 0.64% |
Rhenman & Partners Asset Management AB | 534,000 | $5,329,000 | 0.64% |
Old West Investment Management, LLC | 79,667 | $795,000 | 0.55% |
THREE BAYS CAPITAL LP | 1,284,000 | $12,814,000 | 0.53% |